SA halts rollout of J&J vaccine after US suspension

South Africa has halted the rollout of the Johnson & Johnson vaccine after health agencies in the US recommended its suspension.
Published on

Health Minister Zweli Mkhize told reporters on Tuesday that South Africa will suspend its rollout "until the Johnson & Johnson vaccine is sufficiently interrogated".

By S'thembile Cele and Paul Vecchiatto

(Bloomberg) – South Africa has halted the rollout of Johnson & Johnson vaccines after health agencies in the US recommended its suspension, citing concerns about rare and severe blood clotting side effects.

South Africa will suspend its vaccine rollout "until the Johnson & Johnson vaccine is sufficiently interrogated," Health Minister Zweli Mkhize told reporters on Tuesday. "We hope that the deliberations will only take a few days. Given the preliminary literature on hand, our scientists are confident that the FDA decision is only on a precautionary basis and we expect that this will not result in the complete withdrawal of the Johnson & Johnson vaccine from the vaccination armament."

Related Stories

No stories found.
BizNews
www.biznews.com